We're now a few weeks off the Mar-17 Quarterly (FY16's was released Apr-13th.)
Mar-16s Quarterly posted revenues of $2.94m (Which was the 1st clean quarter without the medivet contribution). Given the Dec-16 Quarter came in at $3.4m, I'm hoping for anything around $3.3m, which would be growth of roughly 10% on previous year's clean quarter. However with the stated decrease in OEM revenue, which is to be partially offset in the latter parts of this FY by new Clements and Ardo revenue, I suspect revenue might be closer to the $3m level.
The past couple weeks have seen a small SP increase on low turnover, with a bid ask wide enought to drive a truck through currently! I've reviewed many other small cap ASX stocks and still find it hard to believe there isn't more interest, given its a growing, profitable company with a solid management team and decent annual revenue. It has the potential to be trading on fairly healthy ratios should the growth trend continue over the next few quarters....
all IMO, DYOR etc...
MLA Price at posting:
6.0¢ Sentiment: Buy Disclosure: Held
